Pharmacists are key members of the oncology care team involved in ensuring patients with breast cancer understand the intricate dosing, sequencing, and adverse effect profiles of specialized regimens. The 2026 Breast Cancer Day of Education provides oncology pharmacists with evidence-based updates on the use of targeted therapies including CDK4/6 inhibitors, PARP inhibitors, and HER2-targeted agents. Join PTCE for a full day of expert-led, case-based discussions designed to support understanding of mutational testing, managing challenging adverse effects, and driving patient adherence in both early-stage and metastatic disease.

Accreditation Information

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Each CE broadcast/symposium is approved for application-based credit.

Obtaining Credit

All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the event.